Ernexa Therapeutics Inc. ( NASDAQ : ERNA )

Sector: Healthcare | Industry: Biotechnology

Pre-Market	Intra-Day	After-Hours
3.66 ( -0.71 / -16.25% )	3.98 ( -0.29 / -6.79% )	3.92 ( -0.06 / -1.51% )
15-Sep 09:19	15-Sep 15:59	15-Sep 17:14

Previous Close	4.27	52-Week Low	3.18
Open	3.78	52-Week High	71.50
Day Low	3.65	50-Day Average	4.68
Day High	4.70	200-Day Average	12.31
Volume	521.36 K	Market Cap	1.25 M

Press Releases - ERNA

Latest press releases and announcements for ERNA .

Showing 1 – 1 of 1 press releases for ERNA from 2026-09-15 to 2026-09-15

15-Sep-2026 08:42

ERNA

Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing

GlobeNewsWire

ERNA-201 demonstrated encouraging disease-modifying activity in the industry-standard collagen-induced arthritis model, providing meaningful proof-of-concept for Ernexa's engineered synthetic iMSC platform beyond oncology